HERSHBERG ROBERT — SEC Form 4 filings

SEC reporting owner CIK 1274139. 16 Form 4 filings on record with FilingPulse; latest filed 2026-09-11.

Transaction summary — filings shown

Covers all 16 filings on record, filed 2024-02-12 to 2026-09-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Adaptive Biotechnologies Corp (ADPT)Director64 legs · 106,632 sh · $1,517,9667
AtaiBeckley Inc. (ATAI)Director31 leg · 100,000 sh · $496,00010
HilleVax, Inc. (HLVX)President and CEO, Director33 legs · 38,132 sh · $221,8223
RECURSION PHARMACEUTICALS, INC. (RXRX)Director35
Atai Beckley N.V. (ATAI)Director14

Form 4 filings — HERSHBERG ROBERT

FiledFormIssuerReported transactionsSource
2026-09-114AtaiBeckley Inc. (ATAI)Disposition to issuer (D): 48,858 (derivative) · Disposition to issuer (D): 404,869 (derivative) · Disposition to issuer (D): 62,394 (derivative) · Disposition to issuer (D): 103,000 (derivative) · Disposition to issuer (D): 121,968 (derivative)EDGAR
2026-08-204Adaptive Biotechnologies Corp (ADPT)Option exercise (M): 15,000 @ $6.32 · Sale (S): 15,000 @ $24.39 · Sale (S): 15,664 @ $24.41 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2026-07-094AtaiBeckley Inc. (ATAI)Option exercise (M): 48,858 @ $1.35 · Option exercise (M): 51,142 @ $1.35 · Sale (S): 100,000 @ $4.96 · Option exercise (M): 48,858 (derivative) @ $0 · Option exercise (M): 51,142 (derivative) @ $0EDGAR
2026-06-224RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 88,424 @ $0EDGAR
2026-06-084AtaiBeckley Inc. (ATAI)Grant/award (A): 121,968 (derivative) @ $0EDGAR
2026-03-064Adaptive Biotechnologies Corp (ADPT)Grant/award (A): 15,625 @ $0EDGAR
2025-12-124Adaptive Biotechnologies Corp (ADPT)Sale (S): 22,968 @ $16EDGAR
2025-11-064Atai Beckley N.V. (ATAI)Grant/award (A): 456,011 (derivative) @ $0 · Grant/award (A): 97,716 (derivative) @ $0 · Grant/award (A): 62,394 (derivative) @ $0 · Grant/award (A): 103,000 (derivative) @ $0EDGAR
2025-09-174HilleVax, Inc. (HLVX)Code (U): 1,101,498EDGAR
2025-06-234RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 22,016 @ $0 · Grant/award (A): 44,031 (derivative) @ $0EDGAR
2025-03-124Adaptive Biotechnologies Corp (ADPT)Sale (S): 53,000 @ $7.59EDGAR
2025-03-064Adaptive Biotechnologies Corp (ADPT)Grant/award (A): 15,394 @ $0 · Grant/award (A): 23,726 (derivative) @ $0EDGAR
2025-02-124HilleVax, Inc. (HLVX)Sale (S): 14,634 @ $1.89 · Sale (S): 11,901 @ $1.76EDGAR
2024-06-054RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 13,097 @ $0 · Grant/award (A): 26,193 (derivative) @ $0EDGAR
2024-03-064Adaptive Biotechnologies Corp (ADPT)Grant/award (A): 31,328 @ $0 · Grant/award (A): 48,044 (derivative) @ $0EDGAR
2024-02-124HilleVax, Inc. (HLVX)Sale (S): 11,597 @ $14.93 · Grant/award (A): 174,202 @ $0 · Grant/award (A): 226,885 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1274139 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →